STAT3 and ovarian carcinoma: CCL11 is a cytokine that induces MEK-1, ERK1/2, and STAT3 phosphoproteins as a mechanism for conferring anti-apoptotic and cisplatin-resistance potential in ovarian carcinoma [55].